| 1. The spinal cord | |
| a) | Is part of the CNS | b) | Is covered by meninges | c) | Extends posteriorly to the 2nd sacral vertebra | d) | Two of these |
| 2. The dorsal horn | |
| a) | Is part of the grey mater | b) | Is also called the posterior horn | c) | Is the location that the spinal thalamic system enters/leaves the CNS | d) | All of these |
| 3. Connects the fourth ventricle with central canal | |
| a) | Foramen of Monroe | b) | Foramen of Luschka | c) | Foramen of Magendie | d) | Aqueduct of Sylvius |
| 4. The arachnoid villi | |
| a) | Protrude into the subarachoid space | b) | Produce CSF | c) | Project into the dural sinuses | d) | Two of these |
| 5. CSF would likely be found in | |
| a) | A ventricle | b) | The sub-arachnoid space | c) | The central canal | d) | All of these |
| 6. Lumbar spinal nerves | |
| a) | All inervate dermatomes | b) | Some but not all may have a visceral function | c) | Contain the dorsal column system | d) | All of these |
| 7. Cranial nerve with a SVA function | |
| a) | Optic | b) | I | c) | IV | d) | Abducens |
| 8. Cranial nerve(s) that has something to do with the eye | |
| a) | Abducens | b) | V | c) | Trochlear | d) | Two of these |
| 9. None of IX cranial nerve | |
| a) | Vestibulocochlear | b) | Vagus | c) | Facial | d) | Glossopharyngeal |
| 10. Cranial nerve with a SVE function | |
| a) | VI | b) | Trigeminal | c) | Vestibulocochlear | d) | IX |
| 11. The generator (receptor) potential | |
| a) | Can be of varying magnitudes | b) | Directly and linearly dictates the frequency of impulses in the afferent neuron | c) | Would decline faster in a phasic receptor than in a tonic receptor | d) | All of these |
| 12. The effector is in the myotatic reflex | |
| a) | Annulospiral ring | b) | Interfusal fibers | c) | A-gamma muscle | d) | Skeletal muscle |
| 13. The dorsal column system | |
| a) | Synapses in the ventral posterolateral nucleus | b) | Is proprioreceptive | c) | Terminates in the parietal lobe | d) | Two of these |
| 14. Pathway that corrects muscle movement | |
| a) | Rubrospinal | b) | Pyramidal | c) | Dentata-Thalamo-Cortico | d) | Spinal Cerebellar |
| 15. Pathway with GSE function | |
| a) | Cortico-pontile-cerebellar | b) | Pyramidal | c) | Tectospinal | d) | Two of these |
| 16. Associated with the nucleus gracilis | |
| a) | Dorsal column | b) | Spinal thalamic | c) | Pyramidal | d) | Dentata-thalamo-cortico |
| 17. Strychnine competes for same receptors as this neurotransmitter | |
| a) | GABA | b) | Glutamate | c) | Serotonin | d) | Glycine |
| 18. Capsaicin influences the release of | |
| a) | Nitric oxide | b) | Substance P | c) | Opiods | d) | GABA |
| 19. Thought to play a role in depression and manic depression | |
| a) | Serotonin | b) | Glycine | c) | Dopamine | d) | GABA |
| 20. Disease associated with chicken pox | |
| a) | Reye's syndrome | b) | Meningitis | c) | Encephalitis | d) | None of these |
| 21. The mid-cervical ganglion | |
| a) | Is "served" by preganglionic fibers from cervical spinal-nerves | b) | Has N-1 receptors on it | c) | Is composed of nerve cell bodies of post ganglionic sympathetic neurons | d) | Two of these |
| 22. At adrenergic sites | |
| a) | COMT is found in the cytoplasm of the post synaptic structure | b) | Uptake-1 accounts for most of the "tunning off" of the synapse | c) | L-DOPA is converted to dopamine by a decarboxylase | d) | All of these |
| 23. Cholinomimetics typically are used for | |
| a) | Glaucoma | b) | Asthma | c) | Ulcers | d) | Two of these |
| 24. A drug that would typically be used during an intubation | |
| a) | N-2 against | b) | N-2 against | c) | A muscarinic blocker | d) | None of these |
| 25. Drugs like Mestinon might be used | |
| a) | To treat hypertension | b) | To treat asthma | c) | To treat myasthenia gravis | d) | As nasal decongestants |
| 26. Black widow venom is to cholinergic sites as _____________ is to adrenergic sites | |
| a) | Cocaine | b) | Ephedrine | c) | Ismelin | d) | Botulin |
| 27. Alpha agonists may be used to treat | |
| a) | Hypertension | b) | Hypotension | c) | Nasal congestion | d) | All of these |
| 28. Might be used to treat hypertension | |
| a) | A muscarinic blocker | b) | A beta-1 against | c) | An N-1 blocker | d) | A beta-2 blockers |
| 29. Beta blockers are used to treat | |
| a) | Angina | b) | Migraines | c) | Glaucoma | d) | All of these |
| 30. Number of thoracic spinal nerves as compared to the number of cranial nerves | |
| a) | Increase or greater than | b) | Decrease or less than | c) | No effect or equal to |
| 31. Number of thoracic spinal nerves with a somatic efferent function as compared to the number of thoracic spinal nerves with a somatic afferent function | |
| a) | Increase or greater than | b) | Decrease or less than | c) | No effect or equal to |
| 32. Number of cervical spinal nerves with a visceral function as compared to the number of sacnal spinal nerves with a sympathetic function | |
| a) | Increase or greater than | b) | Decrease or less than | c) | No effect or equal to |
| 33. Number of neurons in the spinal cerebellar pathway as compared to the dentata-thalamo-cortico pathway | |
| a) | Increase or greater than | b) | Decrease or less than | c) | No effect or equal to |
| 34. Number of meninges as compared to the number of lumbar spinal nerves (pairs) with a sympathetic function | |
| a) | Increase or greater than | b) | Decrease or less than | c) | No effect or equal to |
| 35. Likelihood of an N-1 receptors at preganglionic sympathetic sites as compared to the likelihood of finding them at preganglionic parasympathetic sites | |
| a) | Increase or greater than | b) | Decrease or less than | c) | No effect or equal to |
| 36. Likelihood of an M-1 receptor being excitatory as compared to the likelihood of an M-2 receptor being excitatory | |
| a) | Increase or greater than | b) | Decrease or less than | c) | No effect or equal to |
| 37. Number of muscarinic receptors as compared to the number of nictonic receptors | |
| a) | Increase or greater than | b) | Decrease or less than | c) | No effect or equal to |
| 38. Isoproterenol's affinity for beta receptors as compared to its affinity for alpha receptors | |
| a) | Increase or greater than | b) | Decrease or less than | c) | No effect or equal to |
| 39. Effect of stimulating muscarinic receptors on the diameter of arterioles | |
| a) | Increase or greater than | b) | Decrease or less than | c) | No effect or equal to |
| 40. Effect of stimulating the alpha receptors on the nasopharyngeal glands on the production of mucus | |
| a) | Increase or greater than | b) | Decrease or less than | c) | No effect or equal to |
| 41. Effect of sympathetic stimulation on the production of sweat by the eccrine sweat glands | |
| a) | Increase or greater than | b) | Decrease or less than | c) | No effect or equal to |
| 42. Effect of imiprium on sympathetic activity | |
| a) | Increase or greater than | b) | Decrease or less than | c) | No effect or equal to |
| 43. Effect of Ditropin on contraction of skeletal muscles | |
| a) | Increase or greater than | b) | Decrease or less than | c) | No effect or equal to |
| 44. Effect of Dobutrex on the diameter of the bronchi | |
| a) | Increase or greater than | b) | Decrease or less than | c) | No effect or equal to |
| 45. Effect of Hytrin on the diameter of blood vessels | |
| a) | Increase or greater than | b) | Decrease or less than | c) | No effect or equal to |
| 46. Effect of Timoptic plus ACH on the diameter of the bronchi | |
| a) | Increase or greater than | b) | Decrease or less than | c) | No effect or equal to |
| 47. Effect of Cardura plus epi on heart rate | |
| a) | Increase or greater than | b) | Decrease or less than | c) | No effect or equal to |
| 48. Effect of tropicamide plus pilocarpine on the size of the pupil | |
| a) | Increase or greater than | b) | Decrease or less than | c) | No effect or equal to |
| 49. Effect of phentolamine plus Dobutrex on renin secretion | |
| a) | Increase or greater than | b) | Decrease or less than | c) | No effect or equal to |
| 50. Superior mesenteric ganglia | |
| a) | Parasympathetic Efferent | b) | Parasympathetic Afferent | c) | Sympathetic Efferent | d) | More than 1 of above choices are correct |
| 51. Beta receptors | |
| a) | Parasympathetic Efferent | b) | Parasympathetic Afferent | c) | Sympathetic Efferent | d) | More than 1 of above choices are correct |
| 52. Spinal nerves | |
| a) | Parasympathetic Efferent | b) | Parasympathetic Afferent | c) | Sympathetic Efferent | d) | More than 1 of above choices are correct |
| 53. Long pre-ganglionic fiber | |
| a) | Parasympathetic Efferent | b) | Parasympathetic Afferent | c) | Sympathetic Efferent | d) | More than 1 of above choices are correct |
| 54. N-1 receptors | |
| a) | Parasympathetic Efferent | b) | Parasympathetic Afferent | c) | Sympathetic Efferent | d) | More than 1 of above choices are correct |
| 55. Thirst | |
| a) | Parasympathetic Efferent | b) | Parasympathetic Afferent | c) | Sympathetic Efferent | d) | More than 1 of above choices are correct |
| 56. MAO | |
| a) | Parasympathetic Efferent | b) | Parasympathetic Afferent | c) | Sympathetic Efferent | d) | More than 1 of above choices are correct |
| 57. Causes ciliary muscle to contract | |
| a) | Parasympathetic Efferent | b) | Parasympathetic Afferent | c) | Sympathetic Efferent | d) | More than 1 of above choices are correct |
| 58. Causes the release of renin | |
| a) | Parasympathetic Efferent | b) | Parasympathetic Afferent | c) | Sympathetic Efferent | d) | More than 1 of above choices are correct |
| 59. Ritodrine | |
| a) | Parasympathetic Efferent | b) | Parasympathetic Afferent | c) | Sympathetic Efferent | d) | More than 1 of above choices are correct |
| 60. Cholinergic | |
| a) | Parasympathetic Efferent | b) | Parasympathetic Afferent | c) | Sympathetic Efferent | d) | More than 1 of above choices are correct |